1. Home
  2. GEOS vs ANL Comparison

GEOS vs ANL Comparison

Compare GEOS & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • ANL
  • Stock Information
  • Founded
  • GEOS 1980
  • ANL 2004
  • Country
  • GEOS United States
  • ANL Cayman Islands
  • Employees
  • GEOS N/A
  • ANL N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • ANL
  • Sector
  • GEOS Industrials
  • ANL
  • Exchange
  • GEOS Nasdaq
  • ANL Nasdaq
  • Market Cap
  • GEOS 72.9M
  • ANL 61.8M
  • IPO Year
  • GEOS 1997
  • ANL 2023
  • Fundamental
  • Price
  • GEOS $16.29
  • ANL $1.79
  • Analyst Decision
  • GEOS
  • ANL Hold
  • Analyst Count
  • GEOS 0
  • ANL 1
  • Target Price
  • GEOS N/A
  • ANL N/A
  • AVG Volume (30 Days)
  • GEOS 192.8K
  • ANL 11.6K
  • Earning Date
  • GEOS 08-07-2025
  • ANL 09-23-2025
  • Dividend Yield
  • GEOS N/A
  • ANL N/A
  • EPS Growth
  • GEOS N/A
  • ANL N/A
  • EPS
  • GEOS N/A
  • ANL N/A
  • Revenue
  • GEOS $115,527,000.00
  • ANL N/A
  • Revenue This Year
  • GEOS N/A
  • ANL N/A
  • Revenue Next Year
  • GEOS N/A
  • ANL N/A
  • P/E Ratio
  • GEOS N/A
  • ANL N/A
  • Revenue Growth
  • GEOS N/A
  • ANL N/A
  • 52 Week Low
  • GEOS $5.51
  • ANL $1.10
  • 52 Week High
  • GEOS $21.60
  • ANL $3.89
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 46.07
  • ANL 60.76
  • Support Level
  • GEOS $15.37
  • ANL $1.65
  • Resistance Level
  • GEOS $17.29
  • ANL $1.91
  • Average True Range (ATR)
  • GEOS 1.39
  • ANL 0.10
  • MACD
  • GEOS -0.49
  • ANL 0.00
  • Stochastic Oscillator
  • GEOS 14.77
  • ANL 58.02

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: